HIND
Price
$2.13
Change
+$0.10 (+4.95%)
Updated
Jul 31 closing price
Capitalization
14.84M
10 days until earnings call
Intraday BUY SELL Signals
KPTI
Price
$1.86
Change
-$0.06 (-3.12%)
Updated
Aug 3, 10:30 AM (EDT)
Capitalization
43.51M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

HIND vs KPTI

HIND vs KPTI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HIND vs. KPTI commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a Hold and KPTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (HIND: $2.13 vs. KPTI: $1.92)
Brand notoriety: HIND and KPTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HIND: 112% vs. KPTI: 2024%
Market capitalization -- HIND: $14.84M vs. KPTI: $43.51M
HIND [@Biotechnology] is valued at $14.84M. KPTI’s [@Biotechnology] market capitalization is $43.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIND’s FA Score shows that 0 FA rating(s) are green whileKPTI’s FA Score has 1 green FA rating(s).

  • HIND’s FA Score: 0 green, 5 red.
  • KPTI’s FA Score: 1 green, 4 red.
According to our system of comparison, HIND is a better buy in the long-term than KPTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIND’s TA Score shows that 3 TA indicator(s) are bullish while KPTI’s TA Score has 4 bullish TA indicator(s).

  • HIND’s TA Score: 3 bullish, 6 bearish.
  • KPTI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KPTI is a better buy in the short-term than HIND.

Price Growth

HIND (@Biotechnology) experienced а +3.16% price change this week, while KPTI (@Biotechnology) price change was -74.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

HIND is expected to report earnings on Aug 13, 2026.

KPTI is expected to report earnings on Aug 03, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KPTI($43.5M) has a higher market cap than HIND($14.8M). HIND YTD gains are higher at: -38.227 vs. KPTI (-73.913). HIND has higher annual earnings (EBITDA): -11.07M vs. KPTI (-147.32M). KPTI has more cash in the bank: 90.8M vs. HIND (8.8M). HIND has less debt than KPTI: HIND (22.5K) vs KPTI (231M). KPTI has higher revenues than HIND: KPTI (151M) vs HIND (153K).
HINDKPTIHIND / KPTI
Capitalization14.8M43.5M34%
EBITDA-11.07M-147.32M8%
Gain YTD-38.227-73.91352%
P/E RatioN/AN/A-
Revenue153K151M0%
Total Cash8.8M90.8M10%
Total Debt22.5K231M0%
FUNDAMENTALS RATINGS
HIND vs KPTI: Fundamental Ratings
HIND
KPTI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5697
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPTI's Valuation (2) in the Biotechnology industry is somewhat better than the same rating for HIND (36) in the null industry. This means that KPTI’s stock grew somewhat faster than HIND’s over the last 12 months.

KPTI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that KPTI’s stock grew similarly to HIND’s over the last 12 months.

HIND's SMR Rating (99) in the null industry is in the same range as KPTI (100) in the Biotechnology industry. This means that HIND’s stock grew similarly to KPTI’s over the last 12 months.

HIND's Price Growth Rating (56) in the null industry is somewhat better than the same rating for KPTI (97) in the Biotechnology industry. This means that HIND’s stock grew somewhat faster than KPTI’s over the last 12 months.

HIND's P/E Growth Rating (100) in the null industry is in the same range as KPTI (100) in the Biotechnology industry. This means that HIND’s stock grew similarly to KPTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HINDKPTI
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HIND
Daily Signal:
Gain/Loss:
KPTI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BB8.500.06
+0.71%
BlackBerry Limited
MBWM60.080.35
+0.59%
Mercantile Bank Corp
O63.87-0.29
-0.45%
Realty Income Corp
KROS10.07-0.15
-1.47%
Keros Therapeutics
IOTR2.97-0.14
-4.50%
iOThree Ltd

HIND and

Correlation & Price change

A.I.dvisor indicates that over the last year, HIND has been loosely correlated with PGEN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if HIND jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIND
1D Price
Change %
HIND100%
+5.20%
PGEN - HIND
48%
Loosely correlated
+5.56%
IMMP - HIND
36%
Loosely correlated
+0.58%
MTNB - HIND
35%
Loosely correlated
-7.44%
ONCY - HIND
32%
Poorly correlated
+0.04%
PHAT - HIND
30%
Poorly correlated
-3.10%
More

KPTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with ARRY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
-72.61%
ARRY - KPTI
35%
Loosely correlated
+2.76%
DMRA - KPTI
33%
Loosely correlated
-0.75%
VTGN - KPTI
31%
Poorly correlated
N/A
VCYT - KPTI
31%
Poorly correlated
-22.52%
HIND - KPTI
29%
Poorly correlated
+5.20%
More